Key Highlights
•
A new study reveals that a combination of two existing antibiotics shows significantly higher effectiveness against drug-resistant tuberculosis, killing 99% of bacterial colonies in lab tests. This breakthrough could offer a cheaper and faster treatment option for millions of patients worldwide who currently face limited therapies.
Source →
•
Researchers identified a previously unknown protein on the surface of the malaria parasite that helps it invade human red blood cells, opening the door for a potential new vaccine target. Blocking this protein in animal models reduced infection rates by over 70%, marking a significant step toward more durable protection against the disease.
Source →
•
A large clinical trial found that a single dose of a new antiviral pill reduces the risk of severe COVID-19 by 85% when taken within 48 hours of symptom onset. If approved, this easy-to-take medication could dramatically lower hospitalizations and serve as a critical tool for managing future outbreaks.
Source →
•
Scientists discovered that a common gut bacterium can neutralize the norovirus, preventing infection in human intestinal cells grown in the lab. This finding suggests that probiotic treatments might one day be used to protect vulnerable populations, such as children and the elderly, from this highly contagious stomach bug.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
